Terms: = Gastric cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
5 results:
1. cGAS regulates the DNA damage response to maintain proliferative signaling in gastric cancer cells.
Liu B; Liu H; Ren F; Liu H; Bukhari I; Fu Y; Wu W; Zhao M; Zhu S; Mo H; Li F; Zheng MB; Tang Y; Zheng P; Mi Y
Oncol Res; 2021; 29(2):87-103. PubMed ID: 37305397
[TBL] [Abstract] [Full Text] [Related]
2. IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer.
Lutz MS; Zekri L; Weßling L; Berchtold S; Heitmann JS; Lauer UM; Jung G; Salih HR
Front Immunol; 2023; 14():1163136. PubMed ID: 37122707
[TBL] [Abstract] [Full Text] [Related]
3. cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers.
Ke X; Hu T; Jiang M
FASEB J; 2022 Jan; 36(1):e22029. PubMed ID: 34907606
[TBL] [Abstract] [Full Text] [Related]
4. Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity.
Voskens CJ; Watanabe R; Rollins S; Campana D; Hasumi K; Mann DL
J Exp Clin Cancer Res; 2010 Oct; 29(1):134. PubMed ID: 20937115
[TBL] [Abstract] [Full Text] [Related]
5. Formation of 2-chloroinosine from guanosine by treatment of HNO(2) in the presence of NaCl.
Suzuki T; Ide H; Yamada M; Morii T; Makino K
Bioorg Med Chem; 2001 Nov; 9(11):2937-41. PubMed ID: 11597475
[TBL] [Abstract] [Full Text] [Related]
